bio

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2025 16:35 ET  | Source: Vor Biopharma CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:…

4 days ago
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTechGRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) --…

1 week ago
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 08, 2025 17:00 ET  | Source: TELA Bio, Inc. MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…

2 weeks ago
MaxCyte Signs Platform License Agreement with Adicet BioMaxCyte Signs Platform License Agreement with Adicet Bio

MaxCyte Signs Platform License Agreement with Adicet Bio

August 04, 2025 08:05 ET  | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of…

3 weeks ago
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International ConferenceINmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International Conference

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International Conference

July 24, 2025 07:00 ET  | Source: INmune Bio, Inc. Boca Raton, July 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio…

4 weeks ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:00 ET  | Source: Vor Biopharma CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:…

1 month ago
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

July 07, 2025 08:00 ET  | Source: KALA BIO, Inc. ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO,…

2 months ago
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic AtrophyBelite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

July 02, 2025 03:00 ET  | Source: Belite Bio, Inc -  500 subjects enrolled across the United States, the United…

2 months ago
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 06, 2025 16:05 ET  | Source: TELA Bio, Inc. MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…

2 months ago
Vanqua Bio to Present at Upcoming Scientific ConferencesVanqua Bio to Present at Upcoming Scientific Conferences

Vanqua Bio to Present at Upcoming Scientific Conferences

CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim…

3 months ago